PT1151746E - Microcapsulas para libertacao sustentada de medicamentos - Google Patents

Microcapsulas para libertacao sustentada de medicamentos

Info

Publication number
PT1151746E
PT1151746E PT00985267T PT00985267T PT1151746E PT 1151746 E PT1151746 E PT 1151746E PT 00985267 T PT00985267 T PT 00985267T PT 00985267 T PT00985267 T PT 00985267T PT 1151746 E PT1151746 E PT 1151746E
Authority
PT
Portugal
Prior art keywords
liberation
microcapsules
sustained
medicinal
sustained medicinal
Prior art date
Application number
PT00985267T
Other languages
English (en)
Inventor
Angel Bonilla Munoz
Antonio Parente Duena
Josep Garces Garces
David Cumillera Colome
Original Assignee
Lipotec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec Sa filed Critical Lipotec Sa
Publication of PT1151746E publication Critical patent/PT1151746E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT00985267T 1999-12-17 2000-12-15 Microcapsulas para libertacao sustentada de medicamentos PT1151746E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009902768A ES2169980B1 (es) 1999-12-17 1999-12-17 Microcapsulas para la liberacion prolongada de farmacos.

Publications (1)

Publication Number Publication Date
PT1151746E true PT1151746E (pt) 2003-07-31

Family

ID=8310957

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00985267T PT1151746E (pt) 1999-12-17 2000-12-15 Microcapsulas para libertacao sustentada de medicamentos

Country Status (13)

Country Link
US (3) US20020187196A1 (pt)
EP (1) EP1151746B1 (pt)
JP (1) JP5021880B2 (pt)
AT (1) ATE234608T1 (pt)
AU (1) AU774680B2 (pt)
BR (1) BRPI0008197B8 (pt)
CA (1) CA2362769C (pt)
DE (1) DE60001717T2 (pt)
DK (1) DK1151746T3 (pt)
ES (2) ES2169980B1 (pt)
MX (1) MXPA01008348A (pt)
PT (1) PT1151746E (pt)
WO (1) WO2001043724A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040097419A1 (en) * 2002-11-19 2004-05-20 Holger Petersen Organic compounds
EP1871348A4 (en) * 2005-03-01 2012-08-01 Sun Pharma Advanced Res Co Ltd PHARMACEUTICAL COMPOSITIONS WITH DELAYED RELEASE
KR20130024987A (ko) * 2005-12-22 2013-03-08 노파르티스 아게 옥트레오티드 및 ２종 이상의 폴리락티드-코-글리콜리드 중합체를 포함하는 서방형 제제
ES2324009B1 (es) * 2007-11-23 2010-05-21 Gp Pharm S.A. Composicion farmaceutica de liberacion sostenida de somatostatina o un analogo suyo.
WO2013096858A1 (en) * 2011-12-22 2013-06-27 Life Technologies Corporation Cell culture media and methods
CN105267153B (zh) * 2015-11-27 2018-05-11 上海苏豪逸明制药有限公司 一种曲普瑞林缓释微粒及其制备方法
CN110954491B (zh) * 2019-12-09 2022-11-15 北京博恩特药业有限公司 用于测量醋酸戈舍瑞林缓释植入剂体外溶出度的方法
JP7371519B2 (ja) 2020-02-14 2023-10-31 村田機械株式会社 自動倉庫

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2151185A (en) 1936-01-16 1939-03-21 Carbide & Carbon Chem Corp Esters of glycol monoesters and acylated hydroxy acids
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
EP0052610A1 (en) 1980-05-29 1982-06-02 NICKLAUS, Helen Carol Stringed musical instrument teaching device and process
GB2132887A (en) * 1982-11-15 1984-07-18 Procter & Gamble Enteric-coated anti-inflammatory compositions
CH661206A5 (fr) 1983-09-23 1987-07-15 Debiopharm Sa Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
ATE61935T1 (de) 1985-02-07 1991-04-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von mikrokapseln.
JP2551756B2 (ja) 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
CH665558A5 (en) 1985-10-09 1988-05-31 Debiopharm Sa Phase sepn. prodn. of microcapsules for water soluble pharmaceuticals - using fluoro-substd. aliphatic hydrocarbon as non-solvent in the hardening stage
GB2209937B (en) 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
CH679207A5 (pt) 1989-07-28 1992-01-15 Debiopharm Sa
IT1243390B (it) 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
SE9100610D0 (sv) * 1991-03-04 1991-03-04 Procordia Ortech Ab Bioresorbable material for medical use
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
WO1994021237A1 (en) 1993-03-15 1994-09-29 The Board Of Regents Of The University Of Michigan System for controlled release of antiarrhythmic agents
US6281506B1 (en) 1995-10-05 2001-08-28 Kabushiki Kaisha Toshiba X-ray imaging apparatus
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
WO1998041190A1 (fr) * 1997-03-18 1998-09-24 Sunstar Inc. Composition conçue pour former des particules solides
GB9718986D0 (en) * 1997-09-09 1997-11-12 Danbiosyst Uk Controlled release microsphere delivery system
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels

Also Published As

Publication number Publication date
JP5021880B2 (ja) 2012-09-12
AU774680B2 (en) 2004-07-01
US20080233198A1 (en) 2008-09-25
DE60001717D1 (de) 2003-04-24
ATE234608T1 (de) 2003-04-15
ES2194793T3 (es) 2003-12-01
MXPA01008348A (es) 2004-03-19
DK1151746T3 (da) 2003-07-21
BRPI0008197B1 (pt) 2017-05-09
ES2169980A1 (es) 2002-07-16
CA2362769A1 (en) 2001-06-21
US20050123618A1 (en) 2005-06-09
ES2169980B1 (es) 2003-11-01
BR0008197A (pt) 2002-01-22
US20020187196A1 (en) 2002-12-12
BRPI0008197B8 (pt) 2021-05-25
CA2362769C (en) 2008-09-09
WO2001043724A1 (es) 2001-06-21
AU2173501A (en) 2001-06-25
EP1151746B1 (en) 2003-03-19
EP1151746A1 (en) 2001-11-07
DE60001717T2 (de) 2004-03-18
US9789064B2 (en) 2017-10-17
JP2003516960A (ja) 2003-05-20

Similar Documents

Publication Publication Date Title
NO995753D0 (no) Gastroretarderende mikrosfaerer med styrt frigivelse for bedret administrasjon av medikament
EP1287822A3 (en) Mesalazine controlled release oral pharmaceutical compositions
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
ATE516812T1 (de) Pharmazeutische formulierungen zur anhaltenden arzneimittelfreisetzung
DZ3227A1 (fr) Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
FI4823U1 (fi) Muunnetulla tavalla vapauttava lääkeformulaatio
DZ2685A1 (fr) Formulation pharmaceutique orale à libération prolongée.
HUP0101237A1 (hu) Elnyújtott kioldódású gyógyszerkészítmények
ITMI20001173A0 (it) Composizioni farmaceutiche a rilascio prolungato per la somministrazione parenterale di sostanze idrofile biologicamente attiva.
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
DE60020501D1 (de) Trimetazidinhaltige Matrixtablette zur verlängerten Wirkstofffreisetzung nach oraler Gabe
ATE226450T1 (de) Gepufferte orthoesterpolymere enthaltende arzneimittel
PT1151746E (pt) Microcapsulas para libertacao sustentada de medicamentos
ZA200001852B (en) Sustained release information.
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
MA26788A1 (fr) COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION
AU5701800A (en) A pharmaceutical tablet system for releasing at least one active substance during a release period subsequent to no-release period
ATE296606T1 (de) Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon
NO971574D0 (no) Medisinmateanordning for tildeling av medisin via munnen særlig beregnet for mindre barn
DE10081277D2 (de) Kapsel mit kontrollierter Wirkstofffreisetzung
ITMI20000972A0 (it) Formulazioni farmaceutiche, a rilascio modificato, con elevata biodisponibilita', contenenti principi attivi ad attivita' antibiotica.
AU2002229434A1 (en) Controlled release microsphere system for administration of drug to the eye
DK0984774T3 (da) Mikrosfærer med gastroretentivt reguleret frigivelse til forbedret lægemiddelafgivelse